CIK 0001661181 · Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-19 | Bilbo Patrick Chief Operating Officer | Grant or award | +184,136 | 949,062 | ||
| 2025-02-19 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +190,475 | 190,475 | ||
| 2025-02-19 | Montecalvo Antonio S. Vice President, Health Policy | Grant or award | +42,493 | 196,680 | ||
| 2025-02-19 | Montecalvo Antonio S. Vice President, Health Policy | Grant or award · Stock Option (Right to Buy) | +43,956 | 43,956 | ||
| 2025-02-19 | Grow Brian Chief Commercial Officer | Grant or award | +183,067 | 670,490 | ||
| 2025-02-19 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +189,369 | 189,369 | ||
| 2025-02-19 | Freedman Lori Chief Admin. and Legal Officer | Grant or award | +162,047 | 594,195 | ||
| 2025-02-19 | Freedman Lori Chief Admin. and Legal Officer | Grant or award · Stock Option (Right to Buy) | +167,625 | 167,625 | ||
| 2025-02-19 | Francisco David Chief Financial Officer | Grant or award | +165,156 | 559,095 | ||
| 2025-02-19 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,841 | 170,841 | ||
| 2025-02-19 | Quintero Gilberto Director | Grant or award | +49,575 | 190,245 | ||
| 2025-02-19 | Lustig Garrett Director | Grant or award | +49,575 | 76,914 | ||
| 2025-02-19 | Leibowitz Arthur S Director | Grant or award | +49,575 | 237,186 | ||
| 2025-02-19 | Korfin Michele Ilene Director | Grant or award | +49,575 | 190,245 | ||
| 2025-02-19 | Gillheeney Gary S. President and CEO | Grant or award | +708,215 | 3,515,323 | ||
| 2025-02-19 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +732,596 | 732,596 | ||
| 2025-02-19 | Giacomin Jon L Director | Grant or award | +49,575 | 192,198 | ||
| 2025-02-19 | Duraibabu Prathyusha Director | Grant or award | +49,575 | 198,219 | ||
| 2025-02-19 | Driscoll Michael Joseph Director | Grant or award | +49,575 | 191,879 | ||
| 2025-02-16 | Montecalvo Antonio S. Vice President, Health Policy | Shares withheld for taxes | −719 | $3.70 | $3K | 154,187 |
Page 6 of 12 · 228 trades